Rapid Readout: Clinical Updates in Multiple Sclerosis From CMSC 2020 - Episode 2
“It was a really fascinating Whitaker presentation that was very dense with information.”
In late May, the Consortium of Multiple Sclerosis Centers (CMSC) launched its annual meeting in a virtual format, offering 4 days’ worth of events and presentations covering a plethora of data and information surrounding the treatment and management of multiple sclerosis (MS) and related diseases. One such presentation was the annual Whitaker Lecture, done this year by Peter Calabresi, MD, of Johns Hopkins University School of Medicine.
As Scott Newsome, DO, MSCS, FAAN, president, CMSC, and associate professor of neurology, Johns Hopkins Medicine, detailed in an interview with NeurologyLive, this year’s talk focused on laying out the punitive mechanisms that play a role in MS disease progression—a particular area of interest in progressive types of MS. Calabresi additionally walked through his own research in remyelination, and the current landscape of MS-related biomarkers.
Newsome offered further detail into each of the objectives of the lecture and shared his perspective on the understanding of MS disease progression, and the role that the induction of—as well as lack of—remyelination can play in the context of progressive MS.